Form 8-K HERON THERAPEUTICS, INC. For: Aug 08

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Form 8-K HERON THERAPEUTICS, INC. For: Aug 08

FDA Approval of Heron Therapeutics' (HRTX) Sustol Removes Major Overhang - Analyst

August 10, 2016 11:14 AM EDT

Leerink affirms Heron Therapeutics (Nasdaq: HRTX) at Outperform with a price target of $33 following FDA approval of Sustol for treatment of chemo induced nausea and vomiting.

Analyst Jason Gerberry commented today: We are still reviewing the package insert, but Sustol... More